Introducing the Metabolic Preload — a ready-to-mix nutrition solution purpose-built for the GLP-1 era — on therapy and beyond.
GLP-1 medications are reshaping metabolic health — and exposing a gap no product was built for. Most people don’t stay on them, much of the weight lost is muscle, and the transition off therapy is largely unsupported. That isn’t a drug problem. It’s a nutrition and continuity problem.
Discontinuation: Thomsen et al., population study of 77,310 adults initiating semaglutide for weight loss, EASD 2025. Lean-mass and micronutrient figures reflect the published GLP-1 body-composition and nutrition literature.
Built on a sunflower protein foundation, SunRise is a metabolic nutrition platform formulated for the GLP-1 nutrition era and purpose-built to a deliberately strict regulatory posture. The reach of our clinically designed products starts at the clinics, leveraging the dietitians, telehealth providers, and metabolic clinicians already guiding their care to drive trial and build trust.
Protein and fiber designed for the realities of GLP-1 use and the transition off — not a repurposed protein shake.
A strict structure/function and regulatory posture, with a clinical study program underway to back what we built.
A partnership-led model through clinicians and physician platforms — distribution that compounds instead of burning cash on direct-to-consumer.
SunRise is led by an operating founder alongside a physician co-founder, with formulation, regulatory, and commercial expertise in-house. The science is being built before the noise — a clinical protocol is in development, and the founding team is investing alongside its earliest backers. We’d rather earn conviction than manufacture hype.
If the GLP-1 continuity gap is a space you think about, we’d welcome a conversation.